Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | IDO1 | P14902 | 1/20 | 0.43 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.42 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.42 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | AGXT | P21549 | 1/20 | 0.41 |
| ▸ | MMP9 | P14780 | 1/20 | 0.40 |
| ▸ | MMP8 | P22894 | 1/20 | 0.40 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10782592 | 0.81 | TSHR (0.44) | TSHRAOC3ALDH1A1IDO1SLC1A3 | |
| SCHEMBL24461337 | 0.79 | SLC1A3 (0.43) | TSHRAOC3ALDH1A1IDO1SLC1A3 | |
| SCHEMBL14199725 | 0.76 | TSHR (0.48) | TSHRAOC3ALDH1A1IDO1SLC1A3 | |
| SCHEMBL1571975 | 0.75 | TSHR (0.52) | TSHRALDH1A1IDO1SLC1A3SLC1A2 | |
| SCHEMBL15003 | 0.75 | TSHR (0.52) | TSHRALDH1A1IDO1SLC1A3SLC1A2 | |
| SCHEMBL6774650 | 0.74 | TSHR (0.57) | TSHRALDH1A1IDO1SLC1A3SLC1A2 | |
| SCHEMBL20028832 | 0.74 | SLC1A3 (0.46) | TSHRAOC3ALDH1A1SLC1A3SLC1A2 | |
| Lithium SCHEMBL9504699 | 0.73 | TSHR (0.50) | TSHRALDH1A1IDO1SLC1A3SLC1A2 | |
| Ammonia Solution, Strong SCHEMBL21518155 | 0.73 | TSHR (0.50) | TSHRALDH1A1IDO1SLC1A3SLC1A2 | |
| SCHEMBL9504704 | 0.73 | TSHR (0.50) | TSHRALDH1A1IDO1SLC1A3SLC1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120136744-A | Novel intermediate of 5-cyanoindole and preparation method thereof | 台州职业技术学院 | 2025-06-13 | — | — | CN | claimed |
| CN-103030598-B | The preparation method of methoxy acrylic bactericide | SHANGHAI HEBEN PHARMACEUTICAL CO., LTD. (CN) | 2016-04-13 | — | — | CN | claimed |
| CN-103626691-B | The preparation method of ZEN 90160 | Shanghai Heben-Eastsun Medicaments Co., Ltd. (CN) | 2015-10-21 | — | — | CN | claimed |
| CN-104151233-A | Preparation method of agricultural bactericide | ZHEJIANG TIDE CROP TECHNOLOGY CO LTD | 2014-11-19 | — | — | CN | claimed |
| CN-103626691-A | Picoxystrobin preparation method | SHANGHAI HEBEN EASTSUN MEDICAMENTS CO LTD | 2014-03-12 | — | — | CN | claimed |
| CN-103030598-A | Method for preparing strobilurin fungicide | SHANGHAI HEBEN EASTSUN MEDICAMENTS CO LTD | 2013-04-10 | — | — | CN | claimed |
| US-6972330-B2 | Contacting N4-acetyl-5',3'-di-O-acetyl-2'-O- methyl cytidine with Lewis acid to form 2'-)-methyladenosine nucleoside which is converted to phosphoramidite | SIRNA THERAPEUTICS, INC. (US) | 2005-12-06 | — | — | US | claimed |
| US-20030204078-A1 | Chemical synthesis of methoxy nucleosides | RIBOZYME PHARMACEUTICALS, INC. | 2003-10-30 | — | — | US | claimed |
| EP-1108724-A2 | Synthesis of methoxy nucleosides and enzymatic nucleic acid molecules | RIBOZYME PHARMACEUTICALS, INC. (US) | 2001-06-20 | — | — | EP | claimed |
| US-5969150-A | FLUORESCENT COMPOUNDS FOR MEDICAL DIAGNOSIS, DRUGS AND LABELS OR FUNGICIDES AND VIRICIDES | THE ROCKEFELLER UNIVERSITY (US) | 1999-10-19 | — | — | US | claimed |
| US-5962675-A | Chemical syntheses of 2'-O-methoxy purine nucleosides | RIBOZYME PHARMACEUTICALS, INC. (US) | 1999-10-05 | — | — | US | claimed |
| EP-0886641-A2 | SYNTHESIS OF METHOXY NUCLEOSIDES AND ENZYMATIC NUCLEIC ACID MOLECULES | RIBOZYME PHARMACEUTICALS, INC. (US) | 1998-12-30 | — | — | EP | claimed |
| WO-1997026270-A2 | SYNTHESIS OF METHOXY NUCLEOSIDES AND ENZYMATIC NUCLEIC ACID MOLECULES | RIBOZYME PHARMACEUTICALS, INC. (US) | 1997-07-24 | — | — | WO | claimed |
| CN-120136744-A | Novel intermediate of 5-cyanoindole and preparation method thereof | 台州职业技术学院 | 2025-06-13 | — | — | CN | disclosed |
| CN-119823092-A | Vinyl sulfate compound, synthesis method and application thereof in secondary battery | 江苏华盛锂电材料股份有限公司 | 2025-04-15 | — | — | CN | disclosed |
| CN-114836033-B | Resin precursor composition, resin film thereof, preparation method and application | 吉林奥来德光电材料股份有限公司 | 2023-08-22 | — | — | CN | disclosed |
| US-3979410-A | Intermediate α-acyl-β-dialkylamino-2-nitrostyrenes | HOFFMANN-LA ROCHE INC. (US) | 1976-09-07 | — | — | US | disclosed |
| US-3976639-A | Intermediates for indoles | HOFFMANN-LA ROCHE INC. (US) | 1976-08-24 | — | — | US | disclosed |
| US-3957607-A | Process for the preparation of lipide soluble complexes of cations, application of the process and use of the complexes | W. MOLLER GLASBLASEREI (CH) | 1976-05-18 | — | — | US | disclosed |
| US-3931225-A | Process for preparing o-nitrobenzylketones | HOFFMANN-LA ROCHE INC. (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030204078-A1 | Chemical synthesis of methoxy nucleosides | UMPS, PNP, NUDT1 | TSHR 4248/4885AOC3 1557/4885ALDH1A1 1953/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.